Form CORRESP - Correspondence:
SEC Accession No. 0001213900-13-005465
Filing Date
2013-09-30
Accepted
2013-09-30 16:56:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 43283
  Complete submission text file 0001213900-13-005465.txt   44246
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: CORRESP
SIC: 6770 Blank Checks